Phase 2 clinical data of an investigational type 2 diabetes therapy, TAK-875 of Takeda Pharmaceutical Company Limited (“Takeda”), were published online first in The Lancet.
Phase 2 Data of GPR40 Agonist Demonstrated Improved Glycemic Control
February 27, 2012 |
Permalink
Warning: Trying to access array offset on value of type bool in /var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php on line 20
Tweet
Warning: Trying to access array offset on value of type bool in /var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php on line 20
Tweet
Posted in Drugs